MARATTO

article · Journal of the ASEAN Federation of Endocrine Societies

Vitamin D Status and Dyslipidaemia among Obese Individuals in Ibadan, Nigeria

Abstract

Objective: Obesity is a major global health concern characterized by an accumulation of excessive body fat, dyslipidaemia and low vitamin D levels. This study aimed to assess the relationship between dyslipidaemia and vitamin D status in obese individuals and the risk of atherogenesis. Methodology: In this cross-sectional study, 140 participants aged 18 to 65 years, were categorized into 4 equal groups of 35 each, based on their body mass index BMI. Baseline and demographic data were obtained using a semi-structured questionnaire. The serum levels of vitamin D, total cholesterol (TC), triglyceride (TG) and HDL-cholesterol (HDL-c) were measured using standard methods. Low-density lipoprotein cholesterol (LDL-c) and atherogenic index in plasma (AIP) were calculated. Results: The vitamin D status was sufficient in all groups but its concentrations decline significantly as BMI increases. Serum TC, TG, LDL-c concentration significantly increases as BMI increases, but HDL-c concentration decreases. The AIP increases as BMI increases. Conclusion: The study provided possible evidence to support the association between dyslipidaemia and inadequate vitamin D status in this cohort of adults with obesity in Ibadan, Nigeria.

Research topics

  • Vitamin D Research Studies
  • HIV-related health complications and treatments
  • Adipokines, Inflammation, and Metabolic Diseases

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.15605/jafes.040.02.09

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.